title: Accelerated drug development through combined phase 2/3 clinical trial design.
authors.affiliation: Department of Ophthalmology, New York University School of Medicine, New York 10016, USA. emmett_cunningham@yahoo.com
authors.forename: Emmett T
authors.initials: ET
authors.lastname: Cunningham
authors.forename: Loni
authors.initials: L
authors.lastname: da Silva
authors.forename: Evelyn M
authors.initials: EM
authors.lastname: Harrison
authors.forename: Marlene W
authors.initials: MW
authors.lastname: Modi
authors.forename: Denis
authors.initials: D
authors.lastname: O'Shaughnessy
authors.forename: David R
authors.initials: DR
authors.lastname: Guyer
mesh_terms: D017322:Clinical Trials, Phase II as Topic / Q000379:methods*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D015195:Drug Design; D004341:Drug Evaluation / Q000379:methods*; D015507:Drugs, Investigational; D006801:Humans; D012107:Research Design
chemical_list: D015507:Drugs, Investigational